Association between sex, systemic iron variation and probability of Parkinson's disease

References

• Nussbaum RL, Ellis CE. Alzheimer's disease and Parkinson's disease. New Engl J Med 2003;348:1356–64.
   PubMed Web of Science ®Google Scholar
• Levenson CW. Trace metal regulation of neuronal apoptosis: from genes to behavior. Physiol Behav 2005;86:399–406.
   PubMed Web of Science ®Google Scholar
• Youdim MB, Fridkin M, Zheng H. Bifunctional drug derivatives of MAO-B inhibitor rasagiline and iron chelator VK-28 as a more effective approach to treatment of brain ageing and ageing neurodegenerative diseases. Mech Ageing Dev 2005;126:317–26.
   PubMed Web of Science ®Google Scholar
• Barnham KJ, Bush AI. Metals in Alzheimer's and Parkinson's diseases. Curr Opin Chem Biol 2008;12:222–8.
   PubMed Web of Science ®Google Scholar
• Castiglioni E, Finazzi D, Goldwurm S, Pezzoli G, Forni G, Girelli D, Maccarinelli F, Poli M, Ferrari M, Cremonesi L, Arosio P. Analysis of nucleotide variations in genes of iron management in patients of Parkinson's disease and other movement disorders. Parkinson's Dis 2010;2011:827693.
   PubMedGoogle Scholar
• He Q, Du T, Yu X, Xie A, Song N, Kang Q, Yu J, Tan L, Xie J, Jiang H. DMT1 polymorphism and risk of Parkinson's disease. Neurosci Lett 2011;501:128–31.
   PubMed Web of Science ®Google Scholar
• Rhodes SL, Buchanan DD, Ahmed I, Taylor KD, Loriot MA, Sinsheimer JS, Bronstein JM, Elbaz A, Mellick GD, Rotter JI, Ritz B. Pooled analysis of iron-related genes in Parkinson's disease: association with transferrin. Neurobiology Dis 2014;62:172–8.
   PubMed Web of Science ®Google Scholar
• Kuhn LC. Iron regulatory proteins and their role in controlling iron metabolism. Metallomics 2014;7:232–43.
   Web of Science ®Google Scholar
• Hochstrasser H, Bauer P, Walter U, Behnke S, Spiegel J, Csoti I, Zeiler B, Bornemann A, Pahnke J, Becker G, Riess O, Berg D. Ceruloplasmin gene variations and substantia nigra hyperechogenicity in Parkinson disease. Neurology 2004;63:1912–7.
   PubMed Web of Science ®Google Scholar
• Hochstrasser H, Tomiuk J, Walter U, Behnke S, Spiegel J, Kruger R, Becker G, Riess O, Berg D. Functional relevance of ceruloplasmin mutations in Parkinson's disease. FASEB J 2005;19:1851–3.
   PubMed Web of Science ®Google Scholar
• Hussain RI, Ballard CG, Edwardson JA, Morris CM. Transferrin gene polymorphism in Alzheimer's disease and dementia with Lewy bodies in humans. Neurosci Lett 2002;317:13–6.
   PubMed Web of Science ®Google Scholar
• Mariani S, Ventriglia M, Simonelli I, Donno S, Bucossi S, Vernieri F, Melgari JM, Pasqualetti P, Rossini PM, Squitti R. Fe and Cu do not differ in Parkinson's disease: a replication study plus meta-analysis. Neurobiol Aging 2013;34:632–3.
   PubMed Web of Science ®Google Scholar
• Candore G, Licastro F, Chiappelli M, Franceschi C, Lio D, Rita Balistreri C, Piazza G, Colonna-Romano G, Grimaldi LM, Caruso C. Association between the HFE mutations and unsuccessful ageing: a study in Alzheimer's disease patients from Northern Italy. Mech Ageing Dev 2003;124:525–8.
   PubMed Web of Science ®Google Scholar
• Guerreiro RJ, Bras JM, Santana I, Januario C, Santiago B, Morgadinho AS, Ribeiro MH, Hardy J, Singleton A, Oliveira C. Association of HFE common mutations with Parkinson's disease, Alzheimer's disease and mild cognitive impairment in a Portuguese cohort. BMC Neurol 2006;6:24.
   PubMedGoogle Scholar
• Kauwe JS, Bertelsen S, Mayo K, Cruchaga C, Abraham R, Hollingworth P, Harold D, Owen MJ, Williams J, Lovestone S, Morris JC, Goate AM. Suggestive synergy between genetic variants in TF and HFE as risk factors for Alzheimer's disease. Am J Med Genet B Neuropsychiatr Genet 2010;153B:955–9.
   PubMed Web of Science ®Google Scholar
• Moalem S, Percy ME, Andrews DF, Kruck TP, Wong S, Dalton AJ, Mehta P, Fedor B, Warren AC. Are hereditary hemochromatosis mutations involved in Alzheimer disease? Am J Med Genet 2000;93:58–66.
   PubMed Web of Science ®Google Scholar
• Gibb WR. Accuracy in the clinical diagnosis of parkinsonian syndromes. Postgrad Med J 1988;64:345–51.
   PubMed Web of Science ®Google Scholar
• Wolf PL. Ceruloplasmin: methods and clinical use. Crit Rev Clin Lab Sci 1982;17:229–45.
   PubMed Web of Science ®Google Scholar
• Siotto M, Pasqualetti P, Marano M, Squitti R. Automation of o-dianisidine assay for ceruloplasmin activity analyses: usefulness of investigation in Wilson's disease and in hepatic encephalopathy. J Neural Transm 2014;121:1281–6.
   PubMed Web of Science ®Google Scholar
• Higgins T. Novel chromogen for serum iron determinations. Clin Chem 1981;27:1619–20.
   PubMed Web of Science ®Google Scholar
• Skikne BS, Flowers CH, Cook JD. Serum transferrin receptor: a quantitative measure of tissue iron deficiency. Blood 1990;75:1870–6.
   PubMed Web of Science ®Google Scholar
• Simo JM, Joven J, Cliville X, Sans T. Automated latex agglutination immunoassay of serum ferritin with a centrifugal analyzer. Clin Chem 1994;40:625–9.
   PubMed Web of Science ®Google Scholar
• Farhoudi M, Taheraghdam A, Farid GA, Talebi M, Pashapou A, Majidi J, Goldust M. Serum iron and ferritin level in idiopathic Parkinson. Pak J Biol Sci 2012;15:1094–7.
   PubMedGoogle Scholar
• Madenci G, Bilen S, Arli B, Saka M, Ak F. Serum iron, vitamin B12 and folic acid levels in Parkinson's disease. Neurochem Res 2012;37:1436–41.
   PubMed Web of Science ®Google Scholar
• Sullivan JL. Iron and the sex difference in heart disease risk. Lancet 1981;1:1293–4.
   PubMed Web of Science ®Google Scholar
• Sullivan JL. Stored iron and ischemic heart disease. Empirical support for a new paradigm. Circulation 1992;86:1036–7.
   PubMed Web of Science ®Google Scholar
• Berge LN, Bonaa KH, Nordoy A. Serum ferritin, sex hormones, and cardiovascular risk factors in healthy women. Arteriosclerosis Thromb 1994;14:857–61.
   PubMed Web of Science ®Google Scholar
• Kiechl S, Willeit J, Egger G, Poewe W, Oberhollenzer F. Body iron stores and the risk of carotid atherosclerosis: prospective results from the Bruneck study. Circulation 1997;96:3300–7.
   PubMed Web of Science ®Google Scholar
• Zacharski LR, Chow B, Lavori PW, Howes PS, Bell MR, DiTommaso MA, Carnegie NM, Bech F, Amidi M, Muluk S. The iron (Fe) and atherosclerosis study (FeAST): a pilot study of reduction of body iron stores in atherosclerotic peripheral vascular disease. Am Heart J 2000;139:337–45.
   PubMed Web of Science ®Google Scholar
• Hong D, Kim YS, Son ES, Kim KN, Kim BT, Lee DJ, Kim KM. Total testosterone and sex hormone-binding globulin are associated with metabolic syndrome independent of age and body mass index in Korean men. Maturitas 2013;74:148–53.
   PubMed Web of Science ®Google Scholar
• Waalen J, von Lohneysen K, Lee P, Xu X, Friedman JS. Erythropoietin, GDF15, IL6, hepcidin and testosterone levels in a large cohort of elderly individuals with anaemia of known and unknown cause. Eur J Haematol 2011;87:107–16.
   PubMed Web of Science ®Google Scholar
• Laaksonen DE, Niskanen L, Punnonen K, Nyyssonen K, Tuomainen TP, Salonen R, Rauramaa R, Salonen JT. Sex hormones, inflammation and the metabolic syndrome: a population-based study. Eur J Endocrinol/Eur Fed Endocr Soc 2003;149:601–8.
   PubMed Web of Science ®Google Scholar
• Shores MM, Smith NL, Forsberg CW, Anawalt BD, Matsumoto AM. Testosterone treatment and mortality in men with low testosterone levels. J Clin Endocrinol Metab. 2012;97:2050–8.
   PubMed Web of Science ®Google Scholar
• Liu Z, Ye F, Zhang H, Gao Y, Tan A, Zhang S, Xiao Q, Zhang B, Huang L, Ye B, Qin X, Wu C, Lu Z, Zhang Y, Liao M, Yang X, Mo Z. The association between the levels of serum ferritin and sex hormones in a large scale of Chinese male population. PLOS One 2013;8:e75908.
   Google Scholar
• Wachnik A, Biro G, Biro L, Korom M, Gergely A, Antal M. Effect of sex hormones on copper, zinc, iron nutritional status and hepatic lipid peroxidation in rats. Die Nahrung 1993;37:28–34.
   PubMedGoogle Scholar
• Hou Y, Zhang S, Wang L, Li J, Qu G, He J, Rong H, Ji H, Liu S. Estrogen regulates iron homeostasis through governing hepatic hepcidin expression via an estrogen response element. Gene 2012;511:398–403.
   PubMed Web of Science ®Google Scholar
• Pichler I, Del Greco MF, Gogele M, Lill CM, Bertram L, Do CB, Eriksson N, Foroud T, Myers RH, Consortium PG, Nalls M, Keller MF, International Parkinson's Disease Genomics C, Wellcome Trust Case Control C, Benyamin B, Whitfield JB, Genetics of Iron Status C, Pramstaller PP, Hicks AA, Thompson JR, Minelli C. Serum iron levels and the risk of Parkinson disease: a Mendelian randomization study. PLOS Med 2013;10:e1001462.
   PubMed Web of Science ®Google Scholar